Geneo develops and markets devices for the aesthetic market, including TriPollar and Oxygeneo treatments, DMA, Voluderm, and TriFractional. Geneo delivers innovation with genuine added value for aesthetic professionals and consumers...... Read More
Geneo develops and markets devices for the aesthetic market, including TriPollar and Oxygeneo treatments, DMA, Voluderm, and TriFractional. Geneo delivers innovation with genuine added value for aesthetic professionals and consumers...... Read More